156 related articles for article (PubMed ID: 34968491)
21. A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial.
Meng W; Dong Y; Liu J; Wang Z; Zhong X; Chen R; Zhou H; Lin M; Jiang L; Gao F; Xu T; Chen Q; Zeng X
Trials; 2009 May; 10():30. PubMed ID: 19419555
[TBL] [Abstract][Full Text] [Related]
22. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
23. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell.
He Q; Xia X; Yao K; Zeng J; Wang W; Wu Q; Tang R; Zou X
Life Sci; 2019 Dec; 239():117010. PubMed ID: 31672578
[TBL] [Abstract][Full Text] [Related]
24. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.
Buss H; Dörrie A; Schmitz ML; Hoffmann E; Resch K; Kracht M
J Biol Chem; 2004 Dec; 279(53):55633-43. PubMed ID: 15489227
[TBL] [Abstract][Full Text] [Related]
25. Molecular level interactions of S100A13 with amlexanox: inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor.
Rani SG; Mohan SK; Yu C
Biochemistry; 2010 Mar; 49(11):2585-92. PubMed ID: 20178375
[TBL] [Abstract][Full Text] [Related]
26. Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective.
Gao Y; Zhang H; Lirussi F; Garrido C; Ye XY; Xie T
Biochem Pharmacol; 2020 Dec; 182():114224. PubMed ID: 32956642
[TBL] [Abstract][Full Text] [Related]
27. Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinases.
Johannes JW; Chuaqui C; Cowen S; Devereaux E; Gingipalli L; Molina A; Wang T; Whitston D; Wu X; Zhang HJ; Zinda M
Bioorg Med Chem Lett; 2014 Feb; 24(4):1138-43. PubMed ID: 24462666
[TBL] [Abstract][Full Text] [Related]
28. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
29. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
Lanzi C; Cassinelli G
Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
[TBL] [Abstract][Full Text] [Related]
30. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?
Chau TL; Gioia R; Gatot JS; Patrascu F; Carpentier I; Chapelle JP; O'Neill L; Beyaert R; Piette J; Chariot A
Trends Biochem Sci; 2008 Apr; 33(4):171-80. PubMed ID: 18353649
[TBL] [Abstract][Full Text] [Related]
31. Novel cross-talk within the IKK family controls innate immunity.
Clark K; Peggie M; Plater L; Sorcek RJ; Young ER; Madwed JB; Hough J; McIver EG; Cohen P
Biochem J; 2011 Feb; 434(1):93-104. PubMed ID: 21138416
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors.
Patnaik A; Rosen LS; Tolaney SM; Tolcher AW; Goldman JW; Gandhi L; Papadopoulos KP; Beeram M; Rasco DW; Hilton JF; Nasir A; Beckmann RP; Schade AE; Fulford AD; Nguyen TS; Martinez R; Kulanthaivel P; Li LQ; Frenzel M; Cronier DM; Chan EM; Flaherty KT; Wen PY; Shapiro GI
Cancer Discov; 2016 Jul; 6(7):740-53. PubMed ID: 27217383
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of deuterium-labelled amlexanox and its metabolic stability against mouse, rat, and human microsomes.
Gan X; Wilson MW; Beyett TS; Wen B; Sun D; Larsen SD; Tesmer JJG; Saltiel AR; Showalter HD
J Labelled Comp Radiopharm; 2019 May; 62(5):202-208. PubMed ID: 30828860
[TBL] [Abstract][Full Text] [Related]
34. TANK-binding kinase 1 (TBK1) modulates inflammatory hyperalgesia by regulating MAP kinases and NF-κB dependent genes.
Möser CV; Stephan H; Altenrath K; Kynast KL; Russe OQ; Olbrich K; Geisslinger G; Niederberger E
J Neuroinflammation; 2015 May; 12():100. PubMed ID: 25997745
[TBL] [Abstract][Full Text] [Related]
35. Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines.
Liu Y; Lu J; Zhang Z; Zhu L; Dong S; Guo G; Li R; Nan Y; Yu K; Zhong Y; Huang Q
Cell Death Dis; 2017 Aug; 8(8):e3022. PubMed ID: 29048430
[TBL] [Abstract][Full Text] [Related]
36. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases.
Chariot A; Leonardi A; Muller J; Bonif M; Brown K; Siebenlist U
J Biol Chem; 2002 Oct; 277(40):37029-36. PubMed ID: 12133833
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.
Pomerantz JL; Baltimore D
EMBO J; 1999 Dec; 18(23):6694-704. PubMed ID: 10581243
[TBL] [Abstract][Full Text] [Related]
38. A clinical evaluation of 5% amlexanox oral paste in the treatment of minor recurrent aphthous ulcers and comparison with the placebo paste: a randomized, vehicle controlled, parallel, single center clinical trial.
Bhat S; Sujatha D
Indian J Dent Res; 2013; 24(5):593-8. PubMed ID: 24355961
[TBL] [Abstract][Full Text] [Related]
39. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family.
Shishibori T; Oyama Y; Matsushita O; Yamashita K; Furuichi H; Okabe A; Maeta H; Hata Y; Kobayashi R
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):583-9. PubMed ID: 10051426
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes.
Ikeda F; Hecker CM; Rozenknop A; Nordmeier RD; Rogov V; Hofmann K; Akira S; Dötsch V; Dikic I
EMBO J; 2007 Jul; 26(14):3451-62. PubMed ID: 17599067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
